CRISPR Therapeutics AG (CRSP)
57.00
-0.04
(-0.07%)
USD |
NASDAQ |
Dec 10, 11:42
CRISPR Therapeutics EPS Diluted (Quarterly): -1.166 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.204 |
| Intellia Therapeutics, Inc. | -0.9196 |
| Novartis AG | 2.020 |
| Beam Therapeutics, Inc. | -1.099 |
| BeOne Medicines Ltd. | 1.092 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -106.44M |
| Revenue (Quarterly) | 0.889M |
| Total Expenses (Quarterly) | 107.33M |
| Enterprise Value | 3.728B |
| Gross Profit Margin (Quarterly) | -6.82K% |
| Profit Margin (Quarterly) | -11.97K% |
| Earnings Yield | -9.79% |
| Normalized Earnings Yield | -8.506 |